VERU - Veru Inc.

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
4.2 0.17 (4.05%)	---	---	---	-0.01 (-0.24%)	0.17 (4.05%)	---	-0.01 (-0.24%)

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.5
Diluted EPS:
Basic P/E:: -8.74
Diluted P/E:
RSI(14) 1m:: 48.87
VWAP:: 4.38
RVol:: 1.2559

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	4.47 +0.08 (+1.82%)	Oct 15 15:27
1m	Price decrease 1m	4.17 -0.15 (-3.47%)	Oct 15 14:21
10m	Price decrease 10m	4.17 -0.15 (-3.47%)	Oct 15 14:21
1m	Price increase 1m	4.23 +0.06 (+1.44%)	Oct 15 12:55
1m	Price increase 1m	4.19 +0.04 (+1.02%)	Oct 15 11:57